Clinical Trial: CHARACTERIZATION OF THE OCULAR SURFACE MICROBIOME IN THE REGION OF EPIRUS AND MACEDONIA (GREECE)

U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07643077) titled 'CHARACTERIZATION OF THE OCULAR SURFACE MICROBIOME IN THE REGION OF EPIRUS AND MACEDONIA (GREECE)' on June 07.

Brief Summary: The effect of latanoprost with preservatives on the ocular surface microbiome

Study Start Date: March 20, 2024

Study Type: OBSERVATIONAL

Condition: Glaucoma

Intervention: DRUG: Latanoprost with preservatives (BAK) once per day for at least 6 months period

Existing studies have primarily assessed these differences by comparing treated glaucoma patients to healthy controls, rather than examining changes within the same individuals over time.

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: University ...